Now, the Chicago pharma has done just that by striking a deal with a slate of generics manufacturers that waylays the entry ...

Researchers believe they have developed a test to identify people who have dormant cancer cells and a drug regimen to kill ...

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

Rapamycin is an immune suppressant often used in organ transplant patients, but it has also been shown to extend life in animals, including flies and mice.

AbbVie doesn’t expect generic Rinvoq products to be launched in the United States before April 2037, per an MSN report.

AbbVie (NYSE:ABBV) announced on Thursday that the company has reached settlements with all generic drugmakers to resolve ...

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

One of the great triumphs of health policy is America’s generic drug market. Nine out of ten U.S. prescriptions are filled with generics. That overwhelming share saves patients and taxpayers hundreds ...

ZyVet Animal Health has launched an FDA-approved generic form of furosemide tablets, used for managing congestive heart ...